Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
ReposiTrak, Inc. (TRAK)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
$6.91-5.21%
Close 2026-11-05 · 1-day change
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.49 → 0.49 EPS · FY ending Jun 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TRAK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain quarterly dividend of $0.02 per share | The company pays a steady $0.02 quarterly dividend. | Intact | Dividend cut below $0.02 per share quarterly | Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, smaller-cap technology business with a value-oriented thesis, not a clearly durable compounder. The long-term thesis is intact, though its signal has softened from favorable to mildly favorable.
TRAK is described as cheap versus peers, while the valuation evidence also points to a notable premium versus peers, making the relative picture mixed. Expectations appear justified rather than broadly stretched, but weak execution quality remains a concern.
Recent financial performance is strong, including a reported earnings beat, and diluted earnings per share rose from $0.26 in 2025-Q2 to $0.28 in 2026-Q2. Management is on track with its earnings-per-share and dividend priorities, while preferred-share redemption is progressing but remains mixed. Near term, a guidance cut is a key risk; smaller company size and recent peer misses also warrant attention.
The thesis depends on continued earnings execution and progress toward completing preferred-share redemption by December 2026. A guidance cut would weaken the setup, while rate cuts or stabilization among major technology peers could provide a more supportive sector backdrop.
Over the next 1 to 3 years, TRAK’s strong recent results and peer-relative value support an intact thesis, but fragile earnings quality, volatile management, and high risk leave meaningful uncertainty. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in ReposiTrak, Inc.'s published investment case. The stated target is >=0.28 USD per share. |
| Broken |
| EPS falls below $0.28 in FY26 |
Diluted EPS: $0.11 per share FY2026-Q4; GAAP. Published target: >=0.28 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Sep 28, 20260.11 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue near $26 million in fiscal 2026 | A primary condition in ReposiTrak, Inc.'s published investment case. The stated target is >=26 million USD. | Broken | Revenue falls below $22.6 million in FY26 | Revenue: $5.576M FY2026-Q4; GAAP. Published target: >=26 million USD. Annual target cannot be compared with a quarterly or TTM observation. Sep 28, 20265,575,843 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain valuation discount vs sector median PE | Its valuation is cheaper than peers, trading at a PE of 24.8 versus 38 for the sector. | Intact | PE rises above 35 without earnings growth | P/E (TTM): 17.72x As of 2026-11-05; trailing twelve months. The target timing and basis require a separate assessment. Nov 5, 202617.7179 ratio · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.49 → $0.49 · observed estimates
$0.03B → $0.03B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-25 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-26 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-27 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-28 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-29 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-30 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-07-31 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-01 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-02 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-03 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-04 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-05 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-06 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-08 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-09 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-10 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-12 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-13 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-14 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-15 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-16 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-17 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-18 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-19 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-20 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-21 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-22 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-23 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-24 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-25 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-26 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-27 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-28 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-29 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-30 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-08-31 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-01 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-02 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-03 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-04 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-05 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-06 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-07 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-08 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-09 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-10 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-11 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-12 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-13 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-14 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-15 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-16 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-17 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-18 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-19 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-20 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-21 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-22 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-23 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-24 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-25 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-26 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-27 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-28 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-29 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-09-30 | $0.49 | $28,600,000 | 1 / 1 |
| 2026-10-01 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-02 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-03 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-04 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-05 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-06 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-07 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-08 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-09 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-10 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-11 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-12 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-13 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-14 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-15 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-16 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-17 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-18 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-19 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-20 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-21 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-22 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-23 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-24 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-25 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-26 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-27 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-28 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-29 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-30 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-10-31 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-11-01 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-11-02 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-11-03 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-11-04 | $0.49 | $28,050,000 | 1 / 1 |
| 2026-11-05 | $0.49 | $28,050,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.